Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (471-480 of 560) with videos related to

Pageof 56
Sort By:
Molecular Cancer Therapeutics|August 13, 2009
A novel hTERT promoter-driven E1A therapeutic for ovarian cancerXiaoming Xie, Jennifer L Hsu, Min-Gew Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule StabilityHailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, et al.
Cancer Investigation|June 18, 2004
Expression of BAG-1 and BcL-2 proteins before and after neoadjuvant chemotherapy of locally advanced breast cancerLajos Pusztai, Savitri Krishnamurti, Jorge Perez Cardona, et al.
The New England Journal of Medicine|October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerR C Bast, T L Klug, E St John, et al.
The American Journal of Medicine|March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activityE Frei, R H Blum, S W Pitman, et al.
Oncogene|September 15, 2015
Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathwayJ Chen, M Bai, C Ning, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2013
CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancerXiaoxiang Chen, Jing Zhang, Wenjun Cheng, et al.
Oncogenesis|December 20, 2016
Linking genomic reorganization to tumor initiation via the giant cell cycleN Niu, J Zhang, N Zhang, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 17, 2007
Prevention and early detection of ovarian cancer: mission impossible?Robert C Bast, Molly Brewer, Changping Zou, et al.
Biomarker Research|August 27, 2024
A metabolite-based liquid biopsy for detection of ovarian cancerJohannes F Fahrmann, Seyyed Mahmood Ghasemi, Chae Y Han, et al.
Pageof 56

Showing results (471-480 of 560) with videos related to

Sort By:
Pageof 56
Molecular Cancer Therapeutics|August 13, 2009
A novel hTERT promoter-driven E1A therapeutic for ovarian cancerXiaoming Xie, Jennifer L Hsu, Min-Gew Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule StabilityHailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, et al.
Cancer Investigation|June 18, 2004
Expression of BAG-1 and BcL-2 proteins before and after neoadjuvant chemotherapy of locally advanced breast cancerLajos Pusztai, Savitri Krishnamurti, Jorge Perez Cardona, et al.
The New England Journal of Medicine|October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerR C Bast, T L Klug, E St John, et al.
The American Journal of Medicine|March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activityE Frei, R H Blum, S W Pitman, et al.
Oncogene|September 15, 2015
Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathwayJ Chen, M Bai, C Ning, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2013
CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancerXiaoxiang Chen, Jing Zhang, Wenjun Cheng, et al.
Oncogenesis|December 20, 2016
Linking genomic reorganization to tumor initiation via the giant cell cycleN Niu, J Zhang, N Zhang, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 17, 2007
Prevention and early detection of ovarian cancer: mission impossible?Robert C Bast, Molly Brewer, Changping Zou, et al.
Biomarker Research|August 27, 2024
A metabolite-based liquid biopsy for detection of ovarian cancerJohannes F Fahrmann, Seyyed Mahmood Ghasemi, Chae Y Han, et al.
Pageof 56